IART — INTEGRA LIFESCIENCES HOLDINGS CORP

—
Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 917520 ·
Last close
$13.55
Market Cap
$1.05B
52W High
$20.49
52W Low
$8.70
ADV30
1,191,062
Next earnings
2026-10-21

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 — — — — — — —
Jun 2026 418,761,000 219,744,000 19,285,000 4,482,000 3,563,490,000 214,415,000 2,520,113,000
Mar 2026 391,918,000 216,982,000 11,470,000 -4,617,000 3,577,726,000 236,809,000 2,535,320,000
Dec 2025 434,925,000 220,865,000 23,040,000 -1,704,000 3,602,001,000 235,048,000 2,558,538,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$85,327,000
Investing CF
$-108,626,000
Financing CF
$21,576,000
CapEx
$-73,727,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-0.09
As of
2026-10-25

Balance + Analyst (yfinance extras)

Retained Earnings
$423,306,000
Inventory
$492,005,000
Receivables
$267,188,000
ST Investments
$59,669,000
EBIT TTM
$91,678,000
Pretax Income TTM
$-179,000
Interest Exp TTM
$91,857,000
Analysts
9

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,656,786,048
EBITDA
$333,417,984
Free Cash Flow
$116,033,128
Enterprise Value
$2,617,931,520
Total Cash
$311,929,984
Total Debt
$2,003,251,968
Shares Out
77,772,506
Trailing EPS
$0.17
Book Value
$13.71
ROE
1.2%
ROA
3.1%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 1,635,245,000 17,995,000 -516,474,000 3,602,001,000 2,558,538,000 1,043,463,000 50,384,000
Dec 2024 1,610,527,000 28,411,000 -6,944,000 4,037,424,000 2,492,144,000 1,545,280,000 129,382,000
Dec 2023 1,541,573,000 111,526,000 67,741,000 3,781,988,000 2,194,104,000 1,587,884,000 139,955,000
Dec 2022 1,557,666,000 238,920,000 180,550,000 3,889,758,000 2,085,355,000 1,804,403,000 264,469,000

TTM Snapshot

Revenues TTM
$1,647,666,000
NetIncome TTM
$-7,243,000
OpCashFlow TTM
—
Assets (Latest)
$3,563,490,000
Forward EPS
$2.39

Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)

max pain strike: $12.50 · spot: $13.86 · call volume: 110 · put volume: 7
Expected Move to 2026-12-18: ±$2.56 (18.51%) — implied range $11.29 – $16.42 · ATM straddle on $15.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
SGP SpyGlass Pharma, Inc. $1.05B $31.43 —
SIBN SI-BONE, Inc. $1.04B $23.16 —
ATEC Alphatec Holdings, Inc. $1.06B $6.94 —
IRMD IRADIMED CORP $1.07B $83.45 —
CBLL Ceribell, Inc. $1.01B $25.97 —

News headlines (Yahoo Finance, 1h cache)

Integra LifeSciences (IART) Stock Could Be A Bargain Based On Cash Flow
2026-11-06 22:16 · Yahoo
Integra LifeSciences to Present at the 2026 UBS Global Healthcare Conference
2026-11-06 13:00 · Yahoo
Integra LifeSciences Holdings (IART) Could Be 41% Undervalued On Third Quarter Profit Turnaround
2026-11-03 01:24 · Yahoo
Integra LifeSciences to Highlight Hands-On Education and Neurosurgery Innovation at CNS 2026 Annual Meeting
2026-10-30 12:30 · Yahoo
3 value stocks we find risky
2026-10-26 20:30 · Yahoo
Integra LifeSciences (IART) Stock Sees Fair Value Cut After Analyst Target Reductions
2026-10-24 11:16 · Yahoo
IART Q3 deep dive: Cincinnati disruption and Tissue Reconstruction challenges weigh on outlook
2026-10-22 08:46 · Yahoo
Why Integra LifeSciences (IART) stock is falling today
2026-10-21 21:26 · Yahoo
Integra: 3 Key Takeaways for Long-Term Investors
2026-10-21 18:11 · Yahoo
Integra (IART) Q3 2026 Earnings Call Transcript
2026-10-21 17:17 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.